Suppr超能文献

基于结构的新型二氢烷氧基苄氧基嘧啶衍生物设计,作为人类免疫缺陷病毒逆转录酶的有效非核苷抑制剂。

Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase.

作者信息

Sudbeck E A, Mao C, Vig R, Venkatachalam T K, Tuel-Ahlgren L, Uckun F M

机构信息

Drug Discovery Program, Hughes Institute, St. Paul, Minnesota 55113, USA.

出版信息

Antimicrob Agents Chemother. 1998 Dec;42(12):3225-33. doi: 10.1128/AAC.42.12.3225.

Abstract

Two highly potent dihydroalkoxybenzyloxopyrimidine (DABO) derivatives targeting the nonnucleoside inhibitor (NNI) binding site of human immunodeficiency virus (HIV) reverse transcriptase (RT) have been designed based on the structure of the NNI binding pocket and tested for anti-HIV activity. Our lead DABO derivative, 5-isopropyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-on e, elicited potent inhibitory activity against purified recombinant HIV RT and abrogated HIV replication in peripheral blood mononuclear cells at nanomolar concentrations (50% inhibitory concentration, <1 nM) but showed no detectable cytotoxicity at concentrations as high as 100 microM.

摘要

基于非核苷抑制剂(NNI)结合口袋的结构,设计了两种靶向人类免疫缺陷病毒(HIV)逆转录酶(RT)的NNI结合位点的高效二氢烷氧基苄氧基嘧啶(DABO)衍生物,并对其抗HIV活性进行了测试。我们的先导DABO衍生物5-异丙基-2-[(甲硫基甲基)硫基]-6-(苄基)-嘧啶-4-(1H)-酮,对纯化的重组HIV RT具有强效抑制活性,并在纳摩尔浓度(50%抑制浓度,<1 nM)下消除外周血单个核细胞中的HIV复制,但在高达100 μM的浓度下未显示出可检测到的细胞毒性。

相似文献

引用本文的文献

3
N-(2-Bromo-phen-yl)thio-urea.N-(2-溴苯基)硫脲
Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 10;66(Pt 4):o789. doi: 10.1107/S1600536810008305.
6
Identifying the binding mode of a molecular scaffold.确定分子支架的结合模式。
J Comput Aided Mol Des. 2004 Jan;18(1):23-40. doi: 10.1023/b:jcam.0000022561.76694.5b.

本文引用的文献

5
Anti-HIV active naphthyl analogues of HEPT and DABO.
Acta Chem Scand (Cph). 1997 Mar;51(3 Suppl):426-30. doi: 10.3891/acta.chem.scand.51-0426.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验